Inroduction: Hepatitis D (HDV) is the most interesting and unique among animal viruses. It causes viral hepatitis D only in individuals already infected with HBV (hepatitis B). This dual infection leads to the most aggressive hepatic dysfunction of all human viral hepatitis.
Aim: This study was made to outline the hepatitis D virus among patients with chronic liver disorders in northeastern Bulgaria, in the sight of virus epidemiology, pathogenicity and viral genotype.
Materials and methods: This is a retrospective study conducted between 2013-2019 at St. Marina University Hospital,Varna, Bulgaria. We have analyzed 418 serum samples from 391 patients with chronic liver disease using ELISA, PCR and HDV sequencing and genotyping.
Results and Discussion: From 391 patients with chronic liver abnormalities, 16.6% (95% CI: 15.9% - 23.8%, n = 65) had an etiological association with HDV in ELISA. We found HDV RNA positive results in 63 out of all 65 anti-HDV Ab (antibody) positive patients (96.9%). Twenty-four of them, or 38.1% (95% CI: 26.1% - 51.2%, n = 24), were on antiviral HBV/HDV therapy. For five of them, or 20.8% (95% CI: 7.1% - 42.2%, n = 5), HDV genotype I was found.
Conclusion: HDV infection has still many mysteries to discover - in terms of pathogenesis, clinical outcome in chronic HBV/HDV-infected individuals, as well as genotype variations and their role in avoiding immune elimination of the virus. All these unanswered questions pose a great challenge to the scientific thought and efforts of humankind to reduce and gradually eliminate viral hepatitis D.
Wedemeyer H, Manns MP. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol. 2010;7(1):31-40. doi: 10.1038/nrgastro.2009.205.
Rizzetto M. Hepatitis D virus: Introduction and Epidemiology. Cold Spring Harb Perspect Med. 2015;5(7):a021576. doi: 10.1101/cshperspect.a021576.
Shirazi R, Ram D, Rakovsky A, Bucris E, Gozlan Y, Lustig Y, et al. Characterization of hepatitis B and delta coinfection in Israel. BMC Infect Dis. 2018;18(1):97. doi: 10.1186/s12879-018-3008-x.
Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48(2):335–52. doi: 10.1016/j.jhep.2007.11.011.
Jardi R, Rodriguez F, Buti M, et al. Role of hepatitis B, C and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology. 2001; 34(2):404-10. doi: 10.1053/jhep.2001.26511.
Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep) Gut. 2000;46(3):420–6. doi: 10.1136/gut.46.3.420.
Parana R, Kay A, Moliner F, Viana S, Silva LK, Salcedo JM, et al. HDV genotypes in the western brazillian Amazon region: a preliminary report. Am J Trop Med Hyg. 2006; 75(3): 475-9.
Chao M, Wang TC, Lin CC, Yung-Liang Wang R, Lin WB, Lee SE, et al. Analyses of a whole-genome inter-clade recombination map of hepatitis delta virus suggest a host polymerase-driven and viral RNA structure-promoted template-switching mechanism for viral RNA recombination. Oncotarget. 2017;8(37):60841-60859. doi: 10.18632/oncotarget.18339.
Nisini R, Paroli M, Accapezzato D, Bonino F, Rosina F, Santantonio T, et al. Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles. J Virol. 1997; 71(3):2241-51. doi: 10.1128/JVI.71.3.2241-2251.1997.
Zachou K, Yurdaydin C, Drebber U, Dalekos GN, Erhardt A, Cakaloglu Y, et. al. Quantitative HBsAg and HDV RNA levels in chronic delta hepatitis. Liver Int. 2010; 30 (3):430-7. doi: 10.1111/j.1478-3231.2009.02140.x.
Abbas Z, Afzal R. Life cycle and pathogenesis of hepatitis D virus: A review. World J of Hepatology. 2013, 5(12): 666-75. doi: 10.4254/wjh.v5.i12.666.
Ivanova L, Russev V. Chronic liver disease and parentally transmitted hepatitis viruses. Eur J Inflamm. 2007; 5(1):1-6. doi:10.1177/1721727X0700500101
Ivanova L, Kyoseva M, Metodiev K, Stojkova J. Serologic hepatitis B virus immunity in health care workers. Eur J Inflamm. 2013; 11(3):733-7. doi: 10.1177/1721727X1301100316.
Noureddin M, Gish R. Hepatitis delta: Epidemiology, diagnosis and management 36 years after discovery. Curr Gastroenterol Rep. 2014; 16(1):365. doi: 10.1007/s11894-013-0365-x.
Delmas AS, Gal F, Gallian P, Goldien E, Laperche S. Increasing prevalence of HDV/HBV infection over 15 years in France. J Clin Virol. 2014;59(2):126-8. doi: 10.1016/j.jcv.2013.11.016.
Manesis EK, Vourli G, Dalekos G, Vasiliadis T, Manolaki N, Hounta A, et al. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study. J Hepatol. 2013;59(5):949–56. doi: 10.1016/j.jhep.2013.07.005.
Celen MK, Ayaz C, Hosoglu S, Geyik MF, Ulug M. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey. Saudi Med J. 2006;27(5):617-20.
Amini N, Alavian SM, Kabir A, Aalaei-Andabili SH, Saiedi Hosseini SY, Rizzetto M. Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis. Hepat Mon. 2013;13:e8210. doi: 10.5812/hepatmon.8210.
Gish RG, Y DH, Kane S, Clark M, Mangahas M, Baqai S, et al. Coinfection with hepatitis B and D: epidemiology, prevalence and disease in patients in northern California. J Gastroenterol Hepatol. 2013;28(9):1521-5. doi: 10.1111/jgh.12217.
Romeo R, Del Ne, Rumi M, Russo A, Sangiovanni A, de Franchis R, et al. A 28-year old study of the course of hepatitis delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology. 2009; 136(5):1629-38. doi: 10.1053/j.gastro.2009.01.052.
EASL.The burden of liver disease in Europe. A review of available epidemiological data. 2013:30-31. Available at: http: //www.easl.eu /medias/ EASLimg/ Discover/ EU/54ae845caec619f_file.pdf
Radjef N, Gordien E, Ivaniushina V, Gault E, Anaïs P, Drugan T, et al. Molecular Phylogenetic Analysis indicate a wide and ancient radiation of African genus of at least seven major clades. J Virol. 2004 Mar;78(5):2537-44. doi: 10.1128/jvi.78.5.2537-2544.2004.
Romeo R, Perbellini R. Hepatitis delta virus: Making the point from virus isolation up to 2014. World J of Hepatol. 2015; 7(22):2389-95. doi: 10.4254/wjh.v7.i22.2389.
Ivaniushina V, Radjef N, Alexeeva M, Gault E, Semenov S, Salhi M, et al. Hepatitis delta virus genotypes I and II cocirculate in an endemic area of Yakutia, Russia. J Gen Virol. 2001; 82(Pt 11):2709-18. doi: 10.1099/0022-1317-82-11-2709.
Braga WS, Oliveira CM, Araujo JR, Castilho Mda C, Rocha JM, Gimaque JB, et al. Chronic HDV/HBV co-infection predictors of disease stage - a case series of HDV-3 patients. J Hepatol. 2014; 61(6):1205-11. doi: 10.1016/j.jhep.2014.05.041.
Watanabe H, Nagayama K, Enomoto N, Chinzei R, Yamashiro T, Izumi N, et al. Chronic hepatitis delta virus infection with genotype IIb variant is correlated with progressive liver disease. J Gen Virol. 2003;84(Pt 12):3275-89. doi: 10.1099/vir.0.19499-0.
Barros LMF, Gomes-Gouvêa MS, Pinho JRR, Alvarado-Mora MV, Dos Santos A, Mendes-Corrêa MC, et al. Hepatitis Delta virus genotype 8 infection in Northeast Brazil: inheritance from African slaves? Virus Res. 2011;160(1-2):333–9.
doi: 10.1016/j.virusres.2011.07.006.
Email this article (Login required) 
